VBI (4170.TWO)
TWD 12.35
(-0.4%)
TWD 12.35
(-0.4%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.6 Million TWD | 75.01% |
| 2022 | -26.41 Million TWD | -416.01% |
| 2021 | 8.35 Million TWD | 112.26% |
| 2020 | -68.17 Million TWD | 24.48% |
| 2019 | -90.26 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -6.51 Million TWD | 0.0% |
| 2024 Q1 | -6.51 Million TWD | -82.32% |
| 2023 Q4 | -3.57 Million TWD | 0.0% |
| 2023 Q2 | 274 Thousand TWD | 0.0% |
| 2023 FY | -6.6 Million TWD | 75.01% |
| 2023 Q1 | 274 Thousand TWD | 105.27% |
| 2023 Q3 | -3.57 Million TWD | -1404.56% |
| 2022 Q3 | -5.19 Million TWD | 0.0% |
| 2022 FY | -26.41 Million TWD | -416.01% |
| 2022 Q4 | -5.19 Million TWD | 0.0% |
| 2021 FY | 8.35 Million TWD | 112.26% |
| 2020 FY | -68.17 Million TWD | 24.48% |
| 2019 FY | -90.26 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 87.252% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 102.63% |
| Level Biotechnology Inc. | 62.9 Million TWD | 110.494% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 88.007% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 89.789% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 96.612% |
| GlycoNex Incorporation | -178.36 Million TWD | 96.299% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 96.03% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | 38.204% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 82.707% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 96.072% |
| Visgeneer Inc. | -19.58 Million TWD | 66.303% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 99.033% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 101.055% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 109.117% |
| Neith Corporation | -40.03 Million TWD | 83.511% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 99.431% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -9.162% |
| Enimmune corporation | -223.74 Million TWD | 97.05% |
| TaiRx, Inc. | -212.29 Million TWD | 96.891% |
| CHO Pharma, Inc. | -306.08 Million TWD | 97.843% |
| EirGenix Inc. | -915.2 Million TWD | 99.279% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 113.27% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 89.575% |
| Lin BioScience, Inc. | -687.19 Million TWD | 99.039% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 95.777% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 128.962% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 90.993% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 86.06% |
| RBC Bioscience Corporation | 6.43 Million TWD | 202.659% |
| BiOptic Inc. | 37.74 Million TWD | 117.487% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 99.041% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 82.239% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 89.274% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 102.402% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 92.834% |
| NaviFUS Corp. | -65.72 Million TWD | 89.957% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 92.506% |
| Sinew Pharma Inc. | -170.92 Million TWD | 96.138% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 90.315% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 105.052% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 97.227% |
| AP Biosciences Inc | -339.29 Million TWD | 98.054% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 98.824% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 88.609% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 178.063% |
| Intech Biopharm Corporation | -337.98 Million TWD | 98.047% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 99.497% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 87.211% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 96.133% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 101.224% |
| TCI GENE Inc. | 11.67 Million TWD | 156.549% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 94.825% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 97.772% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 96.965% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 165.227% |
| PharmaEngine, Inc. | 274.65 Million TWD | 102.403% |
| Savior Lifetec Corporation | 30.03 Million TWD | 121.981% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 104.828% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 99.369% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 94.734% |
| Acepodia, Inc. | -817.31 Million TWD | 99.192% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 98.649% |